Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock

摘要

BackgroundMortality from sepsis and septic shock remains high. Results of trials on intravenous immunoglobulins (IVIG) as adjunctive therapy for sepsis have been conflicting. This is an update of a Cochrane review that was originally published in 1999 and updated in 2002 and 2010.